Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm	Not yet recruiting	Not stated	2026-02-11		NCT06615830

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Columbia Research Laboratories	1
Insel Gruppe AG, University Hospital Bern	224
Klinik Hirslanden, Zurich	6
Prof. Dr. med. Dres. h.c. Jan Schmidt, MME	1

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.